Sign in

Allergy & Asthma Network

@allergyasthmahq.bsky.social
133 followers 109 following 659 posts

🌟 Allergy & Asthma Network unites and advocates on behalf of 60 million Americans with #asthma 😷, #allergies 🤧 and related conditions. Learn more ⬇️ AllergyAsthmaNetwork.org

PostsRepliesMedia
Allergy & Asthma Network @allergyasthmahq.bsky.social · 30/09/2026
Congratulations to DBV Technologies on their Biologics License Application submission to the U.S. FDA for the VIASKIN® Peanut Patch for children ages 4–7. The skin patch delivers tiny amounts of peanut protein to gradually desensitize the immune system, with no oral dosing and no needles.
globenewswire.com
DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years
Châtillon, France, September 29, 2026 DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in...
111
Allergy & Asthma Network @allergyasthmahq.bsky.social · 15/09/2026
New #MYTHBUSTING episode 🎧 Patients often think starting a biologic is irreversible. Is that true? Dr. Giselle Mosnaim, Kortney & Dr. Gupta bust the biggest biologics myths for asthma, COPD & nasal polyps and how to address them in practice.
100
Allergy & Asthma Network @allergyasthmahq.bsky.social · 11/09/2026
AstraZeneca has announced full results from the Phase III OBERON and TITANIA trials evaluating tozorakimab, an investigational biologic, in adults living with COPD.  #COPD #RespiratoryHealth #ClinicalTrials #LungHealth #PatientAdvocacy
astrazeneca-us.com
Tozorakimab demonstrated statistically significant and highly clinically meaningful reduction in COPD exacerbations in OBERON and TITANIA Phase III trials
100
Allergy & Asthma Network @allergyasthmahq.bsky.social · 27/08/2026
Being on medication doesn't mean the risk conversation is over when it comes to September Asthma Peak, especially for adults. Every September, a predictable spike in asthma flares hits, and adults are just as vulnerable as kids, even when their asthma feels stable.
110
Allergy & Asthma Network @allergyasthmahq.bsky.social · 17/08/2026
ARS Pharma has announced that every neffy prescription now includes a carry case at no additional cost to patients which is designed to support making neffy easier to carry so epinephrine is readily accessible at all times.
100
Allergy & Asthma Network @allergyasthmahq.bsky.social · 17/08/2026
Our thoughts are with the family and loved ones of Christy Knowings, beloved for her role on Nickelodeon's "All That," who passed away this week following an asthma attack. Her passing is a heartbreaking reminder that asthma is serious and can be unpredictable.
controlyourasthma.org
Control Your Asthma
Take this quick quiz to find out if your asthma is under control. Know the signs, prevent symptoms, and where to get help.
100
Allergy & Asthma Network @allergyasthmahq.bsky.social · 13/08/2026
Aquestive Therapeutics has announced positive results from its recent studies for Anaphylm™ (dibutepinephrine), an investigational sublingual film designed to deliver epinephrine without an injection.
investors.aquestive.com
Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm™ (dibutepinephrine) Sublingual Film | Aquestive Therapeutics
Human factors and clinical study results support planned resubmission of Anaphylm™ NDA in the third quarter of 2026 Self-administration pharmacokinetic (PK) results were comparable to clinician-admini...
112
Allergy & Asthma Network @allergyasthmahq.bsky.social · 12/08/2026
Do you work with patients who have asthma and chronic sinus problems? The two conditions may be closely related. The nose, sinuses and lungs are part of a “united airway” and that means inflammation in the upper airways can potentially trigger asthma in the lower airways.
100
Allergy & Asthma Network @allergyasthmahq.bsky.social · 30/07/2026
🎧 The food choices you make in your baby's first year could shape their immune system for life. New research suggests that what (and how) you introduce solids may influence your baby's gut microbiome and their risk of developing food allergies.
100
Allergy & Asthma Network @allergyasthmahq.bsky.social · 28/07/2026
Advances in medicine are creating NEW options for people living with chronic hives. Advanced treatments include: • Biologic therapies • A new targeted oral medicine that stops histamine release, called a BTK inhibitor. These options may help achieve better symptom control. More: ChronicHives.info
001
Allergy & Asthma Network @allergyasthmahq.bsky.social · 23/07/2026
⚠️ RECALL ALERT: Unique Pharmaceutical Laboratories is voluntarily recalling 4 lots of Cetirizine HCl Tablets USP 5mg (Zyrtec generic, NDC 16571-401-10) due to possible cross-contamination with ranitidine. This is a risk for anyone allergic to ranitidine. Check your bottles.
fda.gov
Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) Issues Voluntary Nationwide Recall of Cetirizine Hydrochloride Tablets USP 5 mg Due to Potential Cross Contaminati...
FOR IMMEDIATE RELEASE – July 18th, 2026 – Panoli, Gujarat, Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) is voluntarily recalling four lots of Cetirizine Hydroc...
100
Allergy & Asthma Network @allergyasthmahq.bsky.social · 20/07/2026
Chronic hives are more common than most people realize, and more misunderstood. One of the biggest myths we hear from patients: hives must mean an allergy. But when hives last more than 6 weeks, the cause is usually not a specific allergen.
100
Allergy & Asthma Network @allergyasthmahq.bsky.social · 15/07/2026
Los corticosteroides orales (COS) pueden ayudar en situaciones de emergencia, pero su uso excesivo puede provocar efectos secundarios graves. La Dra. Juanita Mora explica los efectos secundarios graves a largo plazo derivados del uso excesivo de COS,
100
Allergy & Asthma Network @allergyasthmahq.bsky.social · 14/07/2026
Symptom burden in #CRSwNP extends beyond congestion. Quality of life indicators such as sleep disruption, fatigue, impaired smell/taste, and reduced daily functioning are common.
100
Allergy & Asthma Network @allergyasthmahq.bsky.social · 13/07/2026
Los bebés no pueden decirnos cuando les pasa algo. Esto hace que reconocer la anafilaxia sea crítico. 🚨Los signos de anafilaxia en bebés pueden incluir: 👶 Urticaria, sarpullido o hinchazón (especialmente en labios o cara) 😮‍💨 Tos, silbidos, o dificultad para respirar 🤢 Vómitos o diarrea
100
Allergy & Asthma Network @allergyasthmahq.bsky.social · 09/07/2026
For most patients with chronic spontaneous urticaria, broad allergy and blood testing rarely identifies a cause, yet it's still routinely ordered. In this #podcast episode, Dr. Michael Blaiss joins Kortney Kwong Hing and Dr. Gupta, to break down the new draft chronic hives guidelines:
110
Allergy & Asthma Network @allergyasthmahq.bsky.social · 30/06/2026
We're presenting two On Demand/Digital sessions at the 2026 National Association of County and City Health Officials 360 Conference, taking place July 14-17 in Louisville, KY and virtually. Last chance to attend virtually- www.naccho360.com/registration/digi… #NA360
000
Allergy & Asthma Network @allergyasthmahq.bsky.social · 29/06/2026
Research into a potential new oral treatment for atopic dermatitis (AD) is moving forward. Kymera Therapeutics has completed enrollment for its BROADEN2 Phase 2b clinical trial of KT-621, an investigational once-daily oral medication (pill) for AD.
investors.kymeratx.com
100
Allergy & Asthma Network @allergyasthmahq.bsky.social · 15/06/2026
⚽ World Cup fever is on! Don't let asthma sideline you. Take your controller meds daily, carry your quick-relief inhaler, know your triggers & follow your action plan. Score a goal for your health 🥅 Visit ControlYourAsthma.org #ControlYourAsthma #WorldCup2026
000
Allergy & Asthma Network @allergyasthmahq.bsky.social · 15/06/2026
Director of Community Support Programs Leandra Tonweber PA-C, to present “Decreased Systemic Steroid Use and Improved Asthma Control After Virtual Asthma Self‑Management Education" at the Association of Pulmonary Advanced Practice Providers National Conference. www.pulmapplive.com
000
Allergy & Asthma Network @allergyasthmahq.bsky.social · 12/06/2026
At Allergy & Asthma Network, we hear it all the time from providers: "My patients don't realize their asthma is uncontrolled." And they're right. If your patients are experiencing any of the following, it's time to revisit their treatment plan:
100
Allergy & Asthma Network @allergyasthmahq.bsky.social · 10/06/2026
The U.S. FDA has approved a new maintenance dosing schedule for @elilillyandcompany.bsky.social Ebgylss (lebrikizumab-lbkz), allowing patients ages 12 and older with moderate-to-severe atopic dermatitis to receive treatment once every eight weeks of a single injection (250 mg/2 mL).
lilly.mediaroom.com
FDA approves Lilly's EBGLYSS® (lebrikizumab-lbkz) for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis
EBGLYSS is now the only approved option that offers as few as six maintenance injections per year with no required topicals from the start INDIANAPOLIS, June 9, 2026 /PRNewswire/ -- Eli Lilly and...
100
Allergy & Asthma Network @allergyasthmahq.bsky.social · 08/06/2026
CMS' new Medicaid work requirements risk cutting off care for people with asthma and other chronic conditions. We oppose this rule and urge states to reduce barriers to coverage. allergyasthmanetwork.org/press-page… #CMS #medicaid #patientsfirst
allergyasthmanetwork.org
Allergy & Asthma Network Statement on Centers for Medicare & Medicaid Services Work Requirements Interim Final Rule
Allergy & Asthma Network CEO Lynda Mitchell issued a statement in response to the Centers for Medicare & Medicaid Services (CMS) interim final rule.
000
Allergy & Asthma Network @allergyasthmahq.bsky.social · 05/06/2026
We’re proud to partner with Mediaplanet on the Lung Health campaign, highlighting tools helping to improve respiratory health and support long-term wellbeing. www.futureofpersonalhealth.com/lung… #LungHealth #BetterBreathing
000
Allergy & Asthma Network @allergyasthmahq.bsky.social · 02/06/2026
Do your patients ever ask you questions about dating with food allergies? Such as... • How do you kiss someone when you have a food allergy? • What about when things get even more intimate? • And what does a safe date night even look like?
100
Allergy & Asthma Network @allergyasthmahq.bsky.social · 30/05/2026
Habla español? Language should never be a barrier to healthcare. Allergy & Asthma Network provides asthma and allergy education resources in Spanish to help more families access trusted information. 🔗 redalergiayasma.org 🔗 ControlarTuAsma.org
000
Allergy & Asthma Network @allergyasthmahq.bsky.social · 29/05/2026
Apogee Therapeutics has announced positive 16-week results from APEX Part B, a Phase 2 study of zumilokibart in adults with moderate-to-severe atopic dermatitis. The study met all of its goals, with 65.9% of participants on the mid-dose seeing at least a 75% improvement in their condition
investors.apogeetherapeutics.com
Apogee Therapeutics to Host Conference Call to Report Part B 16-Week Data from the Phase 2 APEX Trial of Zumilokibart in Patients with Moderate-to-Severe Atopic Dermatitis on May 27, 2026 | Apogee The...
Webcast to be held Wednesday, May 27th at 8:00 a.m. ET SAN FRANCISCO and BOSTON, May 26, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advan...
100
Allergy & Asthma Network @allergyasthmahq.bsky.social · 28/05/2026
Too many people believe their asthma is “fine” even when symptoms interrupt sleep, limit activity, or require frequent quick‑relief inhaler use. These are signs of uncontrolled asthma. Uncontrolled asthma leads to preventable ER visits, missed school and workdays, and avoidable complications.
100
Allergy & Asthma Network @allergyasthmahq.bsky.social · 27/05/2026
Nasal congestion that won’t go away? Loss of smell? It could be chronic rhinosinusitis with nasal polyps which is often driven by Type 2 inflammation. 📝 Take the symptom quiz + explore treatment options: AllergyAsthmaNetwork.org/CRSwNP #CRSwNP #NasalPolyps #Type2Inflammation
000
Allergy & Asthma Network @allergyasthmahq.bsky.social · 27/05/2026
Severe allergies don't have to mean missing out on life and Gregg Clark knows that first hand. With the right preparation and knowledge, you can still enjoy the outdoors, share meals, and be present with the people you love. Visit allergyasthmanetwork.org to learn more.
000
Allergy & Asthma Network @allergyasthmahq.bsky.social · 26/05/2026
Today is #TruthTuesday… Myth: “You can outgrow asthma.” Truth: While symptoms may improve, asthma never truly goes away. Stay on top of your care plan! ✅ More myths busted: allergyasthmanetwork.org/what-is-as…' #AsthmaAwarenessMonth #Asthma
010
Allergy & Asthma Network @allergyasthmahq.bsky.social · 26/05/2026
Our team presented an abstract analyzing 100 Orlando census tracts at the American Thoracic Society (ATS) 2026 International Conference. Data showed higher asthma prevalence and PM2.5 levels than FL averages, plus a link between the two—insights masked in statewide data. #healthequity #ATS2026
000
Allergy & Asthma Network @allergyasthmahq.bsky.social · 26/05/2026
⚠️ Severe Asthma affects 5-10% of people with asthma. Learn how severe asthma is diagnosed, treated, and what happens if asthma is uncontrolled for an extended time: allergyasthmanetwork.org/what-is-as… #Asthma #AsthmaAwarenessMonth
021
Allergy & Asthma Network @allergyasthmahq.bsky.social · 25/05/2026
This Memorial Day, let’s take a moment to honor and remember those who made the ultimate sacrifice in service to our country. Those sacrifices inspire us all and give us courage during trying times. Thank you to all our veterans for protecting our freedom. #MemorialDay
000
Allergy & Asthma Network @allergyasthmahq.bsky.social · 24/05/2026
Living with EoE can impact everyday life from meals to social events. Raising awareness helps people get diagnosed sooner and access care. allergyasthmanetwork.org/health-a-z… #EoE #EosinophilicEsophagitis
000
Allergy & Asthma Network @allergyasthmahq.bsky.social · 23/05/2026
May 30, we will be in Detroit for an Asthma Awareness Month event, bringing free resources to the people who need them most. If your organization is passionate about closing the gap in healthcare, let's connect! calendar.allergyasthmanetwork.org/e…
000
Allergy & Asthma Network @allergyasthmahq.bsky.social · 22/05/2026
Join us in congratulating Allergy & Asthma Network's Director of Community Support Programs and lead asthma educator, Leandra Tonweber PA-C, AE-C, on being chosen as the Association of Asthma Educators’ Asthma Advocate of the Month! #asthmacare #asthmaadvocate #healthequity #trustedmessengers
000
Allergy & Asthma Network @allergyasthmahq.bsky.social · 22/05/2026
📣 Today is World Eosinophilic Esophagitis (EoE) Day! We’re raising awareness of #EoE – a chronic, allergic condition that affects the esophagus and can make swallowing food difficult. EoE is often underdiagnosed, yet it can significantly impact quality of life.
101
Allergy & Asthma Network @allergyasthmahq.bsky.social · 21/05/2026
Asthma. Eczema. Nasal polyps. Chronic hives. Food Allergies. These conditions are often treated in silos but they also frequently share one root cause: Type 2 Inflammation. Up to 80% of atopic dermatitis patients and 80–90% of CRSwNP patients have Type 2 inflammation.
112
Allergy & Asthma Network @allergyasthmahq.bsky.social · 21/05/2026
Early identification of worsening asthma is essential for preventing exacerbations. Our Control Your Asthma campaign highlights key indicators such as nighttime symptoms, increased rescue inhaler use, and reduced activity tolerance.
100
Allergy & Asthma Network @allergyasthmahq.bsky.social · 20/05/2026
Today, in honor of Clinical Trials Day, Allergy & Asthma Network reaffirms our commitment to expanding access, strengthening diversity in research, and ensuring patients have a voice in shaping the future of allergy and asthma treatment. #ClinicalTrialsDay #CTD2026
000
Allergy & Asthma Network @allergyasthmahq.bsky.social · 20/05/2026
Chiesi USA has announced that the U.S. FDA has approved TRIMBOW® (beclomethasone dipropionate/formoterol fumarate/glycopyrrolate) as a single-inhaler triple therapy for the maintenance treatment of asthma in adults.
chiesiusa.com
U.S. FDA Approves Chiesi’s TRIMBOW® Single Inhaler Triple Th
TRIMBOW® (beclomethasone dipropionate/formoterol fumarate/glycopyrrolate; or BDP/FF/G) is the first U.S. FDA-approved product from Chiesi’s respiratory portfolio, bringing with it more than four decad...
100
Allergy & Asthma Network @allergyasthmahq.bsky.social · 19/05/2026
Are we treating the symptom or the system? 🔬 Asthma. Eczema. CRSwNP. Allergic Rhinitis. Food Allergies. EoE. For many people, these aren't separate problems, they share a common root: Type 2 inflammation.
120
Allergy & Asthma Network @allergyasthmahq.bsky.social · 18/05/2026
It’s time to take over Type 2 inflammation Week 💡 Time to connect the dots between asthma, eczema, and more. This week, we’re breaking down Type 2 inflammation…what it is, how it impacts you, and what you can do.
110
Allergy & Asthma Network @allergyasthmahq.bsky.social · 17/05/2026
You get a poster! And you get a poster! Everybody gets a poster! Come see us at booth #2833 at #ATS2026!
000
Allergy & Asthma Network @allergyasthmahq.bsky.social · 17/05/2026
Allergy & Asthma Network is proud to sponsor an American Thoracic Society (ATS) PAR abstract scholarship again this year. Congrats to 2026 recipient Dr. Patricia Andrea dela Cruz! #ATS2026 #RespiratoryHealth #Asthma #HealthEquity #PatientAdvocacy #AllergyAsthmaNetwork #PublicHealth #PAR
000
Allergy & Asthma Network @allergyasthmahq.bsky.social · 16/05/2026
Allergy & Asthma Network proudly joins #ATS2026 PAR's 25th anniversary. It is a privilege to collaborate with fellow leaders committed to advancing patient-centered care. site.thoracic.org/advocacy-patients… #RespiratoryHealth #HealthEquity #PatientAdvocacy #PAR
site.thoracic.org
American Thoracic Society | Public Advisory Roundtable (PAR)
The American Thoracic Society is the world's leading medical society dedicated to accelerating the advancement of global respiratory health through…
000
Allergy & Asthma Network @allergyasthmahq.bsky.social · 15/05/2026
We're headed to ATS 2026 International Conference in Orlando; our team will be presenting “A Spatial Analysis of Air Pollution and Asthma Disparities in Orange County, Florida Using the Asthma Equity Explorer Tool." site.thoracic.org/conference #RespiratoryHealth #Asthma #PatientAdvocacy
site.thoracic.org
American Thoracic Society | Conference
The American Thoracic Society is the world's leading medical society dedicated to accelerating the advancement of global respiratory health through…
000
Allergy & Asthma Network @allergyasthmahq.bsky.social · 15/05/2026
Incyte has recently published new 24-week data from their Phase 3 TRuE-AD4 trial examining Opzelura® (ruxolitinib) cream for atopic dermatitis (AD). The study shows that Opzelura® continues working over 24 weeks in adults with moderate AD who haven't responded well to other common topical treatments
investor.incyte.com
100
Allergy & Asthma Network @allergyasthmahq.bsky.social · 14/05/2026
The constant checklist. The scanning every room. The hypervigilance. Sarah Fry, food allergy mom, shares that food allergy parenting is a lot sometimes but there is support and trustworthy resources available for you. 💙
100